Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.
about
Exploiting base excision repair to improve therapeutic approaches for pancreatic cancerThermotherapy enhances oxaliplatin-induced cytotoxicity in human colon carcinoma cells.Translesion DNA polymerases and cancerNetwork insights on oxaliplatin anti-cancer mechanisms.Evidence for base excision repair processing of DNA interstrand crosslinks.Involvement of p38MAPK-ATF2 signaling pathway in alternariol induced DNA polymerase β expression.DNA polymerases and cancer.DNA damage tolerance: a double-edged sword guarding the genomeBase excision repair targets for cancer therapyBiological and therapeutic relevance of nonreplicative DNA polymerases to cancer.Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers.Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy.A chemical and kinetic perspective on base excision repair of DNA.Enhanced expression of nuclear factor I/B in oxaliplatin-resistant human cancer cell lines.Gut microbiota is critical for the induction of chemotherapy-induced pain.DNA polymerase β deficiency is linked to aggressive breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts.Crosstalk between mismatch repair and base excision repair in human gastric cancer.Dysregulated Expression and Subcellular Localization of Base Excision Repair (BER) Pathway Enzymes in Gallbladder CancerBase and nucleotide excision repair facilitate resolution of platinum drugs-induced transcription blockageStructural and Kinetic Studies of the Effect of Guanine N7 Alkylation and Metal Cofactors on DNA Replication
P2860
Q35596477-74EFB73B-FDE8-40F8-879D-F1065A843B7EQ35761696-16AE2513-6AEE-41B1-91F1-AC8C9B7873B2Q36210704-FBB9D6FF-ABC6-41FD-B709-B5CAE1D16ABCQ36578240-56469707-35B8-46A1-871C-B29D5F2F0980Q36799848-BB986C76-D67D-451B-87B9-7B9F02650B65Q37002736-B370D95D-E2C7-4BB0-A047-6734C2F05B06Q37084895-B36F8A62-1B59-4E29-B422-7A416750DA43Q37187991-377A4609-0E14-441F-BE4D-44906F8D2810Q37948054-806C0ECF-ED55-4E00-9A19-52E1850FF12CQ38026112-1973DC78-C838-4E80-8EDB-2E52D407B16EQ38087850-EEF75EE4-673E-4F5F-99EC-E2CECABEA5A1Q38641139-CA236747-7EF1-4B1E-9B64-594A235334CEQ38862585-E51D0C23-70E8-4024-BBC6-140CD6E2D9EAQ39630287-5A45C630-5297-499A-8899-3494858E2F73Q40132185-C375A947-EE23-4791-B140-918285A384FAQ41135502-9CBE07FB-BEBB-472B-897A-C6223049DA1BQ47105352-96417067-2B01-44F8-B2F9-D6F50A932C9EQ57146599-F8D7E723-DB03-4E8B-8213-1349749C20CCQ58716872-BC64FB5A-9BB6-438E-B7A6-DCB4DB2B5371Q58784820-854B4DE8-88E4-4B60-91D9-BAEBC9EFDAE9
P2860
Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Cells deficient in the base ex ...... e to oxaliplatin chemotherapy.
@en
Cells deficient in the base ex ...... e to oxaliplatin chemotherapy.
@nl
type
label
Cells deficient in the base ex ...... e to oxaliplatin chemotherapy.
@en
Cells deficient in the base ex ...... e to oxaliplatin chemotherapy.
@nl
prefLabel
Cells deficient in the base ex ...... e to oxaliplatin chemotherapy.
@en
Cells deficient in the base ex ...... e to oxaliplatin chemotherapy.
@nl
P2093
P2860
P356
P1433
P1476
Cells deficient in the base ex ...... ve to oxaliplatin chemotherapy
@en
P2093
N H Nicolay
P B Farmer
P G Johnston
R A Sharma
S Caporali
P2860
P2888
P304
P356
10.1038/ONC.2009.327
P407
P577
2009-10-19T00:00:00Z